COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans-Reference-Cited by-同舟云学术

COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans

Published:2023-03 Issue: Volume:126 Page:107084
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Back Sudie E.,Flanagan Julianne C.,Killeen Therese,Saraiya Tanya C.,Brown Delisa G.,Jarnecke Amber M.,Rothbaum Alex O.,Joseph Jane,Ana Elizabeth Santa,de Arellano Abigail,Shoemaker Hannah L.,Dixon Reagan Ashley,Nietert Paul J.,Brady Kathleen T.

Funder

National Institute on Alcohol Abuse and Alcoholism

National Institutes of Health

National Institute of Mental Health

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference61 articles.

1. The burden of co-occurring alcohol use disorder and PTSD in U.S. military veterans: comorbidities, functioning, and suicidality;Norman;Psychol. Addict. Behav.,2018

2. Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness;Petrakis;Am. J. Addict.,2011